한국 성인 천식의 진료 지침 - 대한내과학회

48 한국 성인 천식의 진료 지침
1111 Bloebaum RM, Grant JA, Sur S. Immunomodulation: the future of allergy and asthma treatment.
Curr Opin Allergy Clin Immunol 2004;4:63.
1111 Nelson HS. Advances in upper airway diseases and allergen immunotherapy. J Allergy Clin
Immunol 2004;113:635.
1111 Norman PS. Immunotherapy: 1999-2004. J Allergy Clin Immunol 2004;113:1013.
1111 Haldar P, Pavord ID, Shaw DE, Berry MA, Thomas M, Brightling CE, et al. Cluster analysis and
clinical asthma phenotypes. Am J Respir Crit Care Med 2008;178:218.
1111 Weatherall M, James K, Clay J, Perrin K, Masoli M, Wijesinghe M, et al. Dose-response
relationship for risk of non-vertebral fracture with inhaled corticosteroids. Clin Exp Allergy
2008;38:1451.
1111 Harrold LR, Patterson K, Andrade SE, Dube T, Go AS, Buist AS, et al. Asthma drug use and
the development of Churg-Strauss syndrome (CSS). Pharmacoepidemiology and Drug Safety
2007;16:620.
2222 Jaeschke R, O’Byrne PM, Mejza F, Nair P, Lesniak W, Brozek J, et al. The safety of longacting
beta-agonists among patients with asthma using inhaled corticosteroids: systemic
review and metaanalysis. Am J Respir Crit Care Med 2008;178:1009.
2222 Wenzel SE, Barnes PJ, Bleecker ER, Bousquet J, Busse W, Dahlen SE, et al. A randomized,
double-blind, placebo-controlled study of tumor necrosis factor-alpha blockade in severe
persistent asthma. Am J Respir Crit Care Med 2009;179:549.
2222 Pogson ZE, Antoniak MD, Pacey SJ, Lewis SA, Britton JR, Forgaty AW. Does a low sodium
diet improve asthma control? A randomized controlled trial. Am J Respir Crit Care Med
2008;178:132.
2222 O’Byrne PM, Naya IP, Kallen A, Postma DS, Barnes PJ. Increasing doses of inhaled
corticosteroids compared to adding long-acting inhaled beta2-agonists in achieving asthma
control. Chest 2008;134:1192.
2222 Cates CJ, Cates MJ. Regular treatment with salmeterol for chronic asthma: serious adverse
events. Cochrane Database of Systematic Reviews 2008;3:CD006363.
2222 Salpeter SR, Wall AJ, Buckley NS. Long-acting beta-agonists with and without inhaled
corticosteroids and catastrophic asthma events. Am J Med 2010;123:322.
2222 Nelson H, Bonuccelli C, Radner F, Ottosson A, Carroll KJ, Andersson TL, et al. Safety of
formoterol in patients with asthma: combined analysis of data from double-blind, randomized
controlled trials. J Allergy Clin Immunol 2010;125:390.
2222 Weatherall M, Wijesinghe M, Perrin K, Harwood M, Beasley R. Meta-analysis of the risk of
mortality with salmeterol and the effect of concomitant inhaled corticosteroid therapy. Thorax
2010;65:39.
2222 Wijesinghe M, Weatherall M, Perrin K, Harwood M, Beasley R. Risk of mortality associated with
formoterol: a systematic review and meta-analysis. Eur Respir J 2009;34:803.
2222 Levenson M. Long-acting beta-agonists and adverse asthma events meta-analysis: statistical
briefing package for joint meeting of the Pulmonary-Allergy Drugs Advisory Committee, Drug
Safety and Risk Management Advisory Committee, and Pediatric Advisory Committee on
December 10-11, 2008. 3-27-2010. Ref Type: Internet Communication.
3333 Holgate ST, Noonan M, Chanez P, Busse W, Dupont L, Pavord I, et al. Efficacy/safety of
etanercept in moderate-to-severe asthma: a randomised, controlled trial. Eur Respir J doi:
10.1183/09031936.00063510.
3333 Morjaria JB, Chauhan AJ, Babu KS, Polosa R, Davies DE, Holgate ST. The role of a soluble